Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/30/24 18:21 | 5/28/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Eckelman Brendan P. | CA | O | Chief Sc | S.d | -10,290 | 34.30 | 0 | -300 | -100 | 0 | I | ||||||||||||||
3/2/23 16:17 | 3/1/23 | INBX | Health | BioPrd | Biological Products, (No Diag | Eckelman Brendan P. | CA | O | Chief Sc | S | -968 | 24.21 | 0 | -40 | -2 | 2,356 | I | ||||||||||||||
3/1/23 16:41 | 2/28/23 | INBX | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S | -2 | 25.02 | 0 | 0 | 0 | 3,046 | I | ||||||||||||||
2/2/23 19:26 | 2/1/23 | INBX | Health | BioPrd | Biological Products, (No Diag | Eckelman Brendan P. | CA | O | Chief Sc | S.m | -997 | 24.93 | 0 | -40 | -2 | 2,396 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |